东方生物 (688298.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(东方生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 652,171,856.12501,543,883.09376,045,281.028,767,938,106.377,857,758,801.957,111,240,797.504,746,225,792.78
 营业利润(元) -44,437,855.4360,731,225.57-1,445,689.022,528,210,100.303,695,276,938.503,293,428,963.822,510,660,739.55
 利润总额(元) -46,240,019.2059,216,651.82-37,655,036.312,470,752,364.823,653,295,769.513,269,578,141.202,492,082,567.34
 净利润(元) -67,266,359.1937,946,328.87-46,412,877.002,097,431,236.783,086,360,281.062,776,493,182.112,098,665,411.07
 归属于母公司股东的净利润(元) -72,383,980.7334,807,586.49-50,330,075.152,067,714,327.603,051,534,400.782,741,645,521.812,066,679,758.22
盈利能力:
 销售毛利率(%) 37.1435.4732.7350.7955.5557.4463.57
 销售净利率(%) -10.317.57-12.3423.9239.2839.0444.22
 净资产收益率(%) -0.850.42-0.59----
 总资产报酬率ROA(%) -2.95-1.57-0.35----
 投入资本回报率ROIC(%) -0.840.39-0.5626.5137.0634.6726.17
营运能力:
 存货周转率(次) 0.500.380.44----
 应收账款周转率(次) 1.600.680.38----
 总资产周转率(次) 0.060.050.03----
偿债能力:
 资产负债率(%) 13.5517.0421.6022.2415.2523.1323.46
 股东权益比率(%) 84.8481.2576.8376.2683.4875.6376.00
 已获利息倍数(倍) 1.180.7441.19-3.10-4.94-8.10183.32
 流动比率 7.905.834.533.845.853.783.92
 速动比率 7.295.424.253.615.043.253.48
发展能力:
 营业收入增长率(%) -91.70-92.95-92.08-13.786.1811.43112.28
 营业利润增长率(%) -101.20-98.16-100.06-56.23-19.95-17.5782.28
 税后利润增长率(%) -102.37-98.73-102.44-57.97-22.14-19.2374.20
 净资产增长率(%) -15.80-11.17-9.2319.0457.6266.54145.49
 总资产增长率(%) -17.16-17.33-10.2019.2452.3851.48136.70

前瞻产业研究院